CINECA IRIS Institutional Research Information System

CERAVOLO, ROBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 24.589
AS - Asia 12.376
EU - Europa 9.568
SA - Sud America 1.869
AF - Africa 552
OC - Oceania 41
Continente sconosciuto - Info sul continente non disponibili 14
Totale 49.009
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 23.923
SG - Singapore 3.874
CN - Cina 3.553
IT - Italia 3.261
HK - Hong Kong 2.075
BR - Brasile 1.522
SE - Svezia 1.391
VN - Vietnam 1.050
DE - Germania 988
BG - Bulgaria 774
GB - Regno Unito 558
CA - Canada 491
FR - Francia 489
FI - Finlandia 441
RU - Federazione Russa 401
TR - Turchia 394
AT - Austria 353
UA - Ucraina 293
KR - Corea 292
IN - India 285
JP - Giappone 238
CI - Costa d'Avorio 187
CH - Svizzera 142
BD - Bangladesh 118
AR - Argentina 115
NL - Olanda 108
MX - Messico 96
PL - Polonia 96
IQ - Iraq 84
ES - Italia 79
ZA - Sudafrica 79
SN - Senegal 72
MA - Marocco 58
NG - Nigeria 50
EC - Ecuador 46
PK - Pakistan 46
UZ - Uzbekistan 44
ID - Indonesia 43
VE - Venezuela 41
AU - Australia 38
SA - Arabia Saudita 38
CO - Colombia 36
BE - Belgio 33
CL - Cile 30
IE - Irlanda 30
JO - Giordania 30
LT - Lituania 30
KE - Kenya 29
PY - Paraguay 26
CZ - Repubblica Ceca 25
EG - Egitto 21
PH - Filippine 21
PE - Perù 20
MY - Malesia 19
UY - Uruguay 18
IL - Israele 17
AE - Emirati Arabi Uniti 16
AZ - Azerbaigian 16
NP - Nepal 15
JM - Giamaica 13
DZ - Algeria 12
BJ - Benin 11
BO - Bolivia 11
EU - Europa 11
TW - Taiwan 11
KG - Kirghizistan 10
KZ - Kazakistan 10
LB - Libano 10
OM - Oman 10
PA - Panama 10
AL - Albania 9
DO - Repubblica Dominicana 9
TN - Tunisia 9
GR - Grecia 8
GT - Guatemala 8
IR - Iran 8
PT - Portogallo 8
EE - Estonia 7
ET - Etiopia 7
GE - Georgia 7
LV - Lettonia 7
AM - Armenia 6
CR - Costa Rica 6
HN - Honduras 6
NI - Nicaragua 6
HU - Ungheria 5
PS - Palestinian Territory 5
RS - Serbia 5
AO - Angola 4
BA - Bosnia-Erzegovina 4
CY - Cipro 4
DK - Danimarca 4
GA - Gabon 4
KW - Kuwait 4
LK - Sri Lanka 4
TT - Trinidad e Tobago 4
BB - Barbados 3
BH - Bahrain 3
BN - Brunei Darussalam 3
KH - Cambogia 3
Totale 48.947
Salva come PNG Salva come JPEG
Città #
Ashburn 2.674
Singapore 2.123
Hong Kong 2.054
Woodbridge 1.952
Fairfield 1.862
Dallas 1.507
San Jose 1.487
Ann Arbor 1.348
Houston 1.345
Chandler 1.255
Santa Clara 1.051
Shanghai 924
Milan 876
Seattle 816
Sofia 771
Wilmington 694
New York 615
Cambridge 583
Beijing 570
Serra 525
Boardman 448
Jacksonville 396
Los Angeles 396
Hefei 392
Princeton 381
Ottawa 366
Vienna 313
Lawrence 300
Lauterbourg 289
Seoul 281
Medford 278
Ho Chi Minh City 274
Munich 262
Frankfurt am Main 217
Tokyo 216
Pisa 202
Florence 194
Izmir 193
Nanjing 191
Abidjan 187
Des Moines 181
Hanoi 168
Dearborn 154
Buffalo 145
Council Bluffs 144
London 129
Istanbul 128
Redondo Beach 126
São Paulo 124
Rome 117
Bern 113
Turku 113
Dong Ket 112
Helsinki 108
San Diego 102
Chicago 91
Nanchang 79
Bremen 74
Warsaw 74
Dakar 72
Jüchen 67
Redwood City 65
Norwalk 60
Lancaster 59
Guangzhou 58
Orem 58
Ogden 57
Shenyang 56
Columbus 53
Kunming 53
Lagos 48
Lucca 47
Nuremberg 47
Baghdad 46
Chennai 46
The Dalles 45
Hebei 44
Fuzhou 43
Düsseldorf 40
Johannesburg 40
Tashkent 40
Changsha 39
Brooklyn 38
Pune 38
San Francisco 38
Belo Horizonte 37
Montreal 37
Paris 37
Da Nang 36
Phoenix 35
Mexico City 33
Brussels 32
Rio de Janeiro 32
Toronto 32
Denver 31
Quanzhou 31
Tianjin 31
Casablanca 30
Haiphong 30
Atlanta 29
Totale 34.880
Salva come PNG Salva come JPEG
Nome #
Molecular imaging to track Parkinson's disease and atypical parkinsonisms: new imaging frontiers 382
Randomized trial on the effects of a combined physical/cognitive training in aged MCI subjects: the Train the Brain study 335
Cataract surgery under topical anesthesia in a patient with Parkinson disease and deep brain stimulation: a report of feasibility. 293
Vascular Function Is Improved After an Environmental Enrichment Program: The Train the Brain-Mind the Vessel Study 270
Clinical Correlates of Cerebral Amyloid Deposition in Parkinson's Disease Dementia: Evidence from a PET Study 269
Brain-Derived Neurotrophic Factor (BDNF) and Serotonin Transporter (SERT) in Platelets of Patients with Mild Huntington’s Disease: Relationships with Social Cognition Symptoms 263
Serotonin and neurodegeneration: a preliminary study of platelet serotonin transporter (SERT) in patients with Huntington's disease 255
Effects of combined training on neuropsychiatric symptoms and quality of life in patients with cognitive decline 240
α-Synuclein Heterocomplexes with β-Amyloid Are Increased in Red Blood Cells of Parkinson's Disease Patients and Correlate with Disease Severity 232
Disfunzioni sessuali nel morbo di Parkinson: review 230
Correction to: The Italian Dystonia Registry: rationale, design and preliminary findings (Neurological Sciences, (2017), 38, 5, (819-825), 10.1007/s10072-017-2839-3) 228
The role of vascular factors in late-onset sporadic Alzheimer's disease. Genetic and molecular aspects 227
Gait dynamics in Pisa syndrome and Camptocormia: the role of stride length and hip kinematics 226
Aerobic rehabilitation program for improving muscle function in Parkinson's disease 221
Effects of combined training on neuropsychiatric symptoms and quality of life in patients with cognitive decline 221
Increased production of inflammatory cytokines by circulating monocytes in mesial temporal lobe epilepsy: A possible role in drug resistance 220
Mild affective symptoms in de novo Parkinson's disease patients: relationship with dopaminergic dysfunction 217
The precuneus-a witness for excessive aβ gathering in alzheimer's disease pathology 217
Mesolimbic dopaminergic dysfunction in Parkinson's disease depression: evidence from a 123I-FP-CIT SPECT investigation. 214
α-Synuclein Heteromers in Red Blood Cells of Alzheimer's Disease and Lewy Body Dementia Patients 214
Decreased platelet cytochrome c oxidase activity is accompanied by increased blood lactate concentration during exercise in patients with Alzheimer disease 212
A case of pelvic floor myoclonic jerk syndrome. 212
Neuropathy and levodopa in Parkinson's disease: evidence from a multicenter study. 212
A pilot psychometric study of aberrant salience state in patients with Parkinson's disease and its association with dopamine replacement therapy. 211
Social Cognition and Oxytocin in Huntington’s Disease: New Insights 210
Influences of dopaminergic treatment on motor cortex in Parkinson disease: a MRI/MRS study 208
Increase in Mitochondrial D-Loop Region Methylation Levels in Mild Cognitive Impairment Individuals 206
Caudate dopaminergic denervation and visual hallucinations: Evidence from a 123I-FP-CIT SPECT study 205
Efficacy of a combined therapeutic approach in the management of Pisa Syndrome 205
A single center study: Aβ42/p-Tau181 CSF ratio to discriminate AD from FTD in clinical setting 205
Lack of association between mtDNA haplogroups and Alzheimer's disease in Tuscany 205
Serotoninergic polymorphisms (5-HTTLPR and 5-HT2A): association studies with psychosis in Alzheimer disease. 203
Seven tesla MRI of the substantia nigra in patients with rapid eye movement sleep behavior disorder 203
The hOGG1 Ser326Cys polymorphism and Huntington's disease 201
Leadless cardiac pacemaker implant in a patient with two deep brain stimulators: a peaceful cohabitation beyond prejudices 199
Mitochondrial DNA single deletion in a patient with postural tremor. 193
CSF phosporylated TAU protein levels correlate with cerebral glucose metabolism assessed with PET in Alzheimer's disease 192
The relationship between motor symptom lateralization and cognitive performance in newly diagnosed drug-na?ve patients with Parkinson's disease. 188
Comparison of 3T and 7T susceptibility-weighted angiography of the substantia nigra in diagnosing Parkinson disease 185
Evolution of clinical features in possible DLB depending on FP-CIT SPECT result 185
Bipolar Spectrum disorders in Parkinson's disease: a systematic evaluation 185
Antipsychotic drugs in Huntington's disease 184
Diabetes is associated with postural and cognitive domains in Parkinson's disease. Results from a single-center study. 183
Serotonergic antidepressant drugs and L-dopa-induced dyskinesias in Parkinson's disease. 183
Imaging in Glucocerebrosidase-Associated Parkinsonism: Current Status and Implications for Pathophysiology. 182
Depressive symptoms in Parkinson's disease 181
A single-center, cross-sectional prevalence study of impulse control disorders in Parkinson disease: association with dopaminergic drugs. 180
Acute and chronic effects of clozapine in essential tremor 179
Visual hallucinations in Parkinson's disease are not influenced by polymorphisms of serotonin 5-HT2A receptor and transporter genes 177
No evidence for allelic association of serotonin 2A receptor and transporter gene polymorphisms with depression in Alzheimer disease 177
Postural Abnormalities in Parkinson's Disease: An Epidemiological and Clinical Multicenter Study 177
Oxidative stress assessment in Alzheimer's disease: a clinic setting study 176
Antioxidants in the Diet and Cognitive Function: Which Role for the Mediterranean Life-style? 174
Mild cognitive impairment and cognitive-motor relationships in newly diagnosed drug-naive patients with Parkinson's disease. 173
Psychosis associated to Parkinson's disease in the early stages: Relevance of cognitive decline and depression 173
SSRIs do not worsen Parkinson's disease: Evidence from an open-label, prospective study 171
Expanding the clinical phenotype of DYT5 mutations: is multiple system atrophy a possible one? 171
Imaging of the dopamine transporter predicts pattern of disease progression and response to levodopa in patients with schizophrenia and parkinsonism: A 2-year follow-up multicenter study 170
Morphometric and functional MRI changes in essential tremor with and without resting tremore. 170
The Italian Dystonia Registry: rationale, design and preliminary findings 169
Correlation between vestibular abnormalities and MRI findings in cerebellar ataxia 168
Mild cognitive impairment in De Novo Parkinson's disease according to movement disorder guidelines. 168
Progression of tremor in early stages of Parkinson's disease: a clinical and neuroimaging study 168
Intestinal histomorphological and molecular alterations in patients with Parkinson's disease 167
Myopathic involvement in two cases of Hallervorden-Spatz disease 167
[123I]FP-CIT single photon emission computed tomography findings in drug-induced Parkinsonism 167
Metabolic changes induced by theta burst stimulation of the cerebellum in dyskinetic Parkinson's disease patients 167
Spectrum of addictions in Parkinson's disease: from dopamine dysregulation syndrome to impulse control disorders 166
Association of MRI Measures With Disease Severity and Progression in Progressive Supranuclear Palsy 166
Imaging of the dopamine transporter predicts pattern of disease progression and response to levodopa in patients with schizophrenia and parkinsonism: a 2-year follow-up multicenter study. 165
Association of cerebrospinal fluid α-synuclein with total and phospho-tau181 protein concentrations and brain amyloid load in cognitively normal subjective memory complainers stratified by Alzheimer's disease biomarkers 165
Decision making in de novo Parkinson's disease 164
Event-based prospective memory in newly diagnosed, drug-naive Parkinson's disease patients 164
Clinical variables associated with treatment changes in Parkinson's disease: results from the longitudinal phase of the REASON study. 164
Apomorphine hydrochloride for the treatment of Parkinson's disease. 162
Different Clinical Contexts of Use of Blood Neurofilament Light Chain Protein in the Spectrum of Neurodegenerative Diseases 161
Association between amantadine and the onset of dementia in Parkinson's disease 160
Adherence to anti-Parkinson drug therapy in the "REASON" sample of Italian patients with Parkinson's disease: the linguistic validation of the Italian version of the "Morisky Medical Adherence Scale-8 items". 160
Non-motor symptoms in atypical and secondary parkinsonism: The PRIAMO study 160
Quantitative susceptibility mapping in atypical Parkinsonisms 159
Automated MRI Classification in Progressive Supranuclear Palsy: a Large International Cohort Study 159
Involvement of the Nigrostriatal Pathway in Patients With Idiopathic Normal Pressure Hydrocephalus and Parkinsonism 158
Environmental factors and Parkinson's disease: a case-control study in the Tuscany region of Italy 158
Evaluating the SERCA2 and VEGF mRNAs as potential molecular biomarkers of the onset and progression in huntington's disease 158
The mtDNA A8344G "MERRF" mutation is not a common cause of sporadic Parkinson disease in Italian population 157
The association between motor subtypes and alexithymia in de novo Parkinson's disease. 157
Iowa Gambling Task in de novo Parkinson's disease: a comparison between good and poor performers 157
Comparison of plasmatic interleukins patterns among cognitively unimpaired subjects, patients affected by mild cognitive impairment and subjects with Alzheimer's disease dementia 156
Assessment of midbrain atrophy in patients with progressive supranuclear palsy with routine magnetic resonance imaging 156
Long-term beneficial impact of the randomised trial 'Train the Brain', a motor/cognitive intervention in mild cognitive impairment people: effects at the 14-month follow-up 155
Sindrome da encefalopatia posteriore reversibile (PRES) in una paziente psoriasica in trattamento con ciclosporina 154
Symptomatic orthostatic tremor associated with Graves' disease. 154
A non-comparative assessment of tolerability and efficacy of duloxetine in the treatment of depressed patients with Parkinson's disease 154
Clinical/scientific notes 154
Dissecting the Interplay between Time of Dementia and Cognitive Profiles in Lewy Body Dementias 154
How many parkinsonian patients are suitable candidates for deep brain stimulation of subthalamic nucleus? Results of a questionnaire 153
Connected speech in progressive supranuclear palsy: a possible role in differential diagnosis 153
Prevalence and clinical correlates of comorbid anxiety and panic disorders in patients with Parkinson’s disease 153
Frontal assessment battery scores and non-motor symptoms in parkinsonian disorders 152
Differential diagnosis of dementia with Lewy Bodies and Alzheimer’s disease by scintigraphic evaluaton of dopaminergic degeneration and selective regional cerebral blood flow impairment 151
Totale 18.940
Salva come PNG Salva come JPEG
Categoria #
all - tutte 140.374
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 140.374
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021519 0 0 0 0 0 0 0 0 0 0 136 383
2021/20223.327 44 125 71 254 657 440 91 176 199 99 225 946
2022/20234.283 563 536 340 356 460 539 37 309 760 23 280 80
2023/20243.850 454 412 406 318 561 764 139 134 30 68 178 386
2024/202510.919 115 416 176 569 789 953 1.074 511 1.158 1.562 1.371 2.225
2025/202612.973 949 1.621 1.732 1.225 1.406 1.135 2.034 620 710 1.207 334 0
Totale 49.661